Stay updated on Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial page.

Latest updates to the Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial page
- Check3 days agoChange DetectedRevision note updated: Revision v3.3.4 has been added and Revision v3.3.3 has been removed.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA consolidated Locations section lists all site locations by state and the revision shows v3.3.3. Individual state location subsections (e.g., California Locations, Colorado Locations) were removed.SummaryDifference2%

- Check46 days agoChange DetectedThe page footer revision label was updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page shows a site revision update from v3.2.0 to v3.3.1, with no changes to the study content or essential navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check61 days agoChange DetectedThe funding-status notice about a lapse in government funding and where to check operating status has been removed from the page.SummaryDifference0.3%

- Check75 days agoChange DetectedThe study page content appears unchanged between screenshots; only layout and formatting differ. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of Galegenimab in Geographic Atrophy Clinical Trial page.